Glenmark Trandolapril/Verapamil Tablets Recall: Subpotent Risk

Take action

Contact the company & request your remedy

Recalling firmGlenmark Pharmaceuticals Inc., USA750 Corporate Dr, N/A · Mahwah, NJ 07430-2009

No email on file — write to the address above instead.

✎ GovInfoNow plain-language explainer

What happened, in plain English

Glenmark Pharmaceuticals is recalling a specific prescription tablet combination that may not contain the correct amount of active ingredients. This could lead to ineffective treatment if used as directed.

Why it’s dangerous

The tablets may not contain the full amount of active ingredients due to a manufacturing issue. This could result in the medication being less effective than intended, potentially affecting treatment outcomes.

Who’s affected

Prescription patients who have the 100-count bottle of Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg. Patients on specific blood pressure or heart conditions are most at risk.

How to tell if you have this one

Check for the 100-count bottle labeled 'Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg'. The product is prescription-only with NDC 68462-295-01 and batch number 19224744.

Brand
Glenmark
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Product Details
Verify the product label matches the recalled items: 100-count bottle, 2 mg/180 mg, prescription-only, NDC 68462-295-01.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall indicates potential subpotency, meaning the medication may not contain the full amount of active ingredients. Patients should consult their doctor before using.

What should I do if I have this product?

The official recall notice does not specify a remedy. Patients should check with their doctor about whether to continue using the product.

How can I confirm I have the recalled product?

Look for the NDC code 68462-295-01 and batch number 19224744 on the label. The product is prescription-only.

Take action

Contact Glenmark

We’ve drafted a message you can send Glenmark to request your refund or repair — edit it as you like.

✉️ Open in email

Subject: Recall D-1095-2023 — Glenmark Glenmark

Hello,

I own a Glenmark that is covered by recall D-1095-2023 from Glenmark.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-1095-2023 (August 14, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1095-2023 to see it in context.
Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.

Glenmark Pharmaceuticals Inc., USA recalls Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mg, 100-count Bottle, Rx only,

Lower-risk recall